{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T03:17:49Z","timestamp":1791343069696,"version":"4.3.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2018,9,13]],"date-time":"2018-09-13T00:00:00Z","timestamp":1536796800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Urol Rep"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1007\/s11934-018-0839-3","type":"journal-article","created":{"date-parts":[[2018,9,13]],"date-time":"2018-09-13T05:50:30Z","timestamp":1536817830000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Recurrent Urinary Tract Infections in Females and the Overlap with Overactive Bladder"],"prefix":"10.1007","volume":"19","author":[{"given":"Farnoosh","family":"Nik-Ahd","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Lenore Ackerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Anger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,9,13]]},"reference":[{"issue":"6","key":"839_CR1","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s00345-002-0301-4","volume":"20","author":"WF Stewart","year":"2003","unstructured":"Stewart WF, Van Rooyen JB, Cundiff GW, et al. Prevalence and burden of overactive bladder in the United States. World J Urol. 2003;20(6):327\u201336.","journal-title":"World J Urol"},{"issue":"1","key":"839_CR2","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/S0090-4295(02)02243-4","volume":"61","author":"P Abrams","year":"2003","unstructured":"Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, et al. The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society. Urology. 2003;61(1):37\u201349.","journal-title":"Urology"},{"issue":"2","key":"839_CR3","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1002\/nau.10052","volume":"21","author":"P Abrams","year":"2002","unstructured":"Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, et al. The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn. 2002;21(2):167\u201378.","journal-title":"Neurourol Urodyn"},{"issue":"4","key":"839_CR4","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1097\/01.ju.0000155596.98780.82","volume":"173","author":"TL Griebling","year":"2005","unstructured":"Griebling TL. Urologic diseases in America project: trends in resource use for urinary tract infections in women. J Urol. 2005;173(4):1281\u20137.","journal-title":"J Urol"},{"issue":"3","key":"839_CR5","doi-asserted-by":"publisher","first-page":"331","DOI":"10.2105\/AJPH.80.3.331","volume":"80","author":"B Foxman","year":"1990","unstructured":"Foxman B. Recurring urinary tract infection: incidence and risk factors. Am J Public Health. 1990;80(3):331\u20133.","journal-title":"Am J Public Health"},{"issue":"4","key":"839_CR6","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1086\/315827","volume":"182","author":"D Scholes","year":"2000","unstructured":"Scholes D, Hooton TM, Roberts PL, Stapleton AE, Gupta K, Stamm WE. Risk factors for recurrent urinary tract infection in young women. J Infect Dis. 2000;182(4):1177\u201382.","journal-title":"J Infect Dis"},{"issue":"12","key":"839_CR7","doi-asserted-by":"publisher","first-page":"801","DOI":"10.4111\/kju.2011.52.12.801","volume":"52","author":"R Raz","year":"2011","unstructured":"Raz R. Urinary tract infection in postmenopausal women. Korean J Urol. 2011;52(12):801\u20138.","journal-title":"Korean J Urol"},{"issue":"1","key":"839_CR8","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1086\/313596","volume":"30","author":"R Raz","year":"2000","unstructured":"Raz R, Gennesin Y, Wasser J, Stoler Z, Rosenfeld S, Rottensterich E, et al. Recurrent urinary tract infections in postmenopausal women. Clin Infect Dis. 2000;30(1):152\u20136.","journal-title":"Clin Infect Dis"},{"key":"839_CR9","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1097\/00019048-199902000-00005","volume":"8","author":"R Raz","year":"1999","unstructured":"Raz R. Role of estriol therapy for women with recurrent urinary tract infections: advantages and disadvantages. Infect Dis Clin Pract. 1999;8:64\u20136.","journal-title":"Infect Dis Clin Pract"},{"issue":"11","key":"839_CR10","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1056\/NEJM199309093291102","volume":"329","author":"R Raz","year":"1993","unstructured":"Raz R, Stamm WE. A controlled trial of intravaginal estriol in postmenopausal women with recurrent urinary tract infections. N Engl J Med. 1993;329(11):753\u20136.","journal-title":"N Engl J Med"},{"issue":"6250","key":"839_CR11","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1136\/bmj.281.6250.1243","volume":"281","author":"TM Thomas","year":"1980","unstructured":"Thomas TM, Plymat KR, Blannin J, Meade TW. Prevalence of urinary incontinence. Br Med J. 1980;281(6250):1243\u20135.","journal-title":"Br Med J"},{"issue":"3\u20134","key":"839_CR12","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/0378-5122(81)90041-4","volume":"3","author":"AA Haspels","year":"1981","unstructured":"Haspels AA, Luisi M, Kicovic PM. Endocrinological and clinical investigations in post-menopausal women following administration of vaginal cream containing oestriol. Maturitas. 1981;3(3\u20134):321\u20137.","journal-title":"Maturitas"},{"issue":"8","key":"839_CR13","doi-asserted-by":"publisher","first-page":"2686","DOI":"10.1128\/JCM.00670-15","volume":"53","author":"ME Tomas","year":"2015","unstructured":"Tomas ME, Getman D, Donskey CJ, Hecker MT. Overdiagnosis of urinary tract infection and underdiagnosis of sexually transmitted infection in adult women presenting to an emergency department. J Clin Microbiol. 2015;53(8):2686\u201392.","journal-title":"J Clin Microbiol"},{"issue":"4","key":"839_CR14","doi-asserted-by":"publisher","first-page":"243","DOI":"10.3109\/00365540903470655","volume":"42","author":"H Lindback","year":"2010","unstructured":"Lindback H, Lindback J, Sylvan S, et al. Low frequency of antibiotic resistance among urine isolates of Escherichia coli in the community, despite a major hospital outbreak with Klebsiella pneumoniae producing CTX-M-15 in Uppsala County. Scand J Infect Dis. 2010;42(4):243\u20138.","journal-title":"Scand J Infect Dis"},{"key":"839_CR15","doi-asserted-by":"crossref","unstructured":"Aisen CM, Ditkoff E, RoyChoudhury A, Corish M, Rutman MP, Chung DE, et al. Utility of catheterized specimens in reducing overdiagnosis of urinary tract infections in women. Neurourol Urodyn. 2018;","DOI":"10.1002\/nau.23553"},{"issue":"5 Suppl 2","key":"839_CR16","doi-asserted-by":"publisher","first-page":"S135","DOI":"10.5489\/cuaj.11183","volume":"5","author":"A Wein","year":"2011","unstructured":"Wein A. Symptom-based diagnosis of overactive bladder: an overview. Can Urol Assoc J. 2011;5(5 Suppl 2):S135\u20136.","journal-title":"Can Urol Assoc J"},{"issue":"11","key":"839_CR17","doi-asserted-by":"publisher","first-page":"2469","DOI":"10.1002\/(SICI)1097-0142(19990601)85:11<2469::AID-CNCR24>3.0.CO;2-U","volume":"85","author":"L Cheng","year":"1999","unstructured":"Cheng L, Cheville JC, Neumann RM, Leibovich BC, Egan KS, Spotts BE, et al. Survival of patients with carcinoma in situ of the urinary bladder. Cancer. 1999;85(11):2469\u201374.","journal-title":"Cancer"},{"issue":"5","key":"839_CR18","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1016\/S0022-5347(05)67637-9","volume":"163","author":"KATHLEEN JOY PROPERT","year":"2000","unstructured":"Propert, K.J., A.J. Schaeffer, C.M. Brensinger, et al., A prospective study of interstitial cystitis: results of longitudinal followup of the interstitial cystitis data base cohort. The Interstitial Cystitis Data Base Study Group. J Urol, 2000. 163(5): p. 1434\u20131439.","journal-title":"The Journal of Urology"},{"issue":"4","key":"839_CR19","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/0090-4295(78)90286-8","volume":"12","author":"EM Messing","year":"1978","unstructured":"Messing EM, Stamey TA. Interstitial cystitis: early diagnosis, pathology, and treatment. Urology. 1978;12(4):381\u201392.","journal-title":"Urology"},{"issue":"2","key":"839_CR20","first-page":"75","volume":"64","author":"KJ Oravisto","year":"1975","unstructured":"Oravisto KJ. Epidemiology of interstitial cystitis. Ann Chir Gynaecol Fenn. 1975;64(2):75\u20137.","journal-title":"Ann Chir Gynaecol Fenn"},{"issue":"6","key":"839_CR21","doi-asserted-by":"publisher","first-page":"2118","DOI":"10.1016\/S0022-5347(05)65517-6","volume":"166","author":"A Driscoll","year":"2001","unstructured":"Driscoll A, Teichman JM. How do patients with interstitial cystitis present? J Urol. 2001;166(6):2118\u201320.","journal-title":"J Urol"},{"issue":"21","key":"839_CR22","first-page":"361","volume":"107","author":"G Schmiemann","year":"2010","unstructured":"Schmiemann G, Kniehl E, Gebhardt K, Matejczyk MM, Hummers-Pradier E. The diagnosis of urinary tract infection: a systematic review. Dtsch Arztebl Int. 2010;107(21):361\u20137.","journal-title":"Dtsch Arztebl Int"},{"issue":"2","key":"839_CR23","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/s00192-010-1263-5","volume":"22","author":"E Hessdoerfer","year":"2011","unstructured":"Hessdoerfer E, Jundt K, Peschers U. Is a dipstick test sufficient to exclude urinary tract infection in women with overactive bladder? Int Urogynecol J. 2011;22(2):229\u201332.","journal-title":"Int Urogynecol J"},{"issue":"3\u20134","key":"839_CR24","doi-asserted-by":"publisher","first-page":"E83","DOI":"10.5489\/cuaj.3962","volume":"11","author":"JC Forde","year":"2017","unstructured":"Forde JC, Davila JL, Marks BK, Epstein M, Tsui JF, Weiss JP, et al. Urogynecological conditions associated with overactive bladder symptoms in women. Can Urol Assoc J. 2017;11(3\u20134):E83\u2013e87.","journal-title":"Can Urol Assoc J"},{"issue":"6","key":"839_CR25","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1046\/j.1464-410X.1998.00879.x","volume":"82","author":"MP Mayfield","year":"1998","unstructured":"Mayfield MP, Whelan P. Bladder tumours detected on screening: results at 7 years. Br J Urol. 1998;82(6):825\u20138.","journal-title":"Br J Urol"},{"issue":"3","key":"839_CR26","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1016\/S0022-5347(17)36720-4","volume":"148","author":"JP Britton","year":"1992","unstructured":"Britton JP, Dowell AC, Whelan P, Harris CM. A community study of bladder cancer screening by the detection of occult urinary bleeding. J Urol. 1992;148(3):788\u201390.","journal-title":"J Urol"},{"issue":"1","key":"839_CR27","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1590\/S0041-87812002000100007","volume":"57","author":"ES Rovner","year":"2002","unstructured":"Rovner ES, Gomes CM, Trigo-Rocha FE, et al. Evaluation and treatment of the overactive bladder. Rev Hosp Clin Fac Med Sao Paulo. 2002;57(1):39\u201348.","journal-title":"Rev Hosp Clin Fac Med Sao Paulo"},{"issue":"6 Suppl","key":"839_CR28","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.1016\/j.juro.2012.09.079","volume":"188","author":"EA Gormley","year":"2012","unstructured":"Gormley EA, Lightner DJ, Burgio KL, Chai TC, Clemens JQ, Culkin DJ, et al. Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA\/SUFU guideline. J Urol. 2012;188(6 Suppl):2455\u201363.","journal-title":"J Urol"},{"issue":"6","key":"839_CR29","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1097\/AOG.0000000000000526","volume":"124","author":"DD Rahn","year":"2014","unstructured":"Rahn DD, Carberry C, Sanses TV, Mamik MM, Ward RM, Meriwether KV, et al. Vaginal estrogen for genitourinary syndrome of menopause: a systematic review. Obstet Gynecol. 2014;124(6):1147\u201356.","journal-title":"Obstet Gynecol"},{"issue":"6","key":"839_CR30","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1016\/j.juro.2013.04.142","volume":"190","author":"MA Beerepoot","year":"2013","unstructured":"Beerepoot MA, Geerlings SE, van Haarst EP, et al. Nonantibiotic prophylaxis for recurrent urinary tract infections: a systematic review and meta-analysis of randomized controlled trials. J Urol. 2013;190(6):1981\u20139.","journal-title":"J Urol"},{"key":"839_CR31","first-page":"Cd001405","volume":"10","author":"JD Cody","year":"2012","unstructured":"Cody JD, Jacobs ML, Richardson K, et al. Oestrogen therapy for urinary incontinence in post-menopausal women. Cochrane Database Syst Rev. 2012;10:Cd001405.","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"839_CR32","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1097\/SPV.0000000000000256","volume":"22","author":"DR Ellington","year":"2016","unstructured":"Ellington DR, Szychowski JM, Malek JM, Gerten KA, Burgio KL, Richter HE. Combined tolterodine and vaginal estradiol cream for overactive bladder symptoms after randomized single-therapy treatment. Female Pelvic Med Reconstr Surg. 2016;22(4):254\u201360.","journal-title":"Female Pelvic Med Reconstr Surg"}],"container-title":["Current Urology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11934-018-0839-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11934-018-0839-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11934-018-0839-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,9]],"date-time":"2020-11-09T18:44:22Z","timestamp":1604947462000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11934-018-0839-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,13]]},"references-count":32,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["839"],"URL":"https:\/\/doi.org\/10.1007\/s11934-018-0839-3","relation":{},"ISSN":["1527-2737","1534-6285"],"issn-type":[{"value":"1527-2737","type":"print"},{"value":"1534-6285","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,13]]},"assertion":[{"value":"13 September 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Farnoosh Nik-Ahd declares no potential conflicts of interest. A. Lenore Ackerman reports a 1-year research support grant from Pfizer. Jennifer Anger is an expert witness for Boston Scientific, Inc.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"94"}}